Cabinet approves signing of MoU between India, Suriname in field of medicines regulation
The Memorandum of Understanding will facilitate export of medical products leading to foreign exchange earnings.;
Advertisement
New Delhi: The Union Cabinet, chaired by the Prime Minister Shri Narendra Modi, was apprised of a Memorandum of Understanding (MoU) signed on 4th June, 2023 between the Indian Pharmacopoeia Commission (IPC), Ministry of Health & Family Welfare, Government of the Republic of India and Ministry of Health, Government of the Republic of Suriname for Recognition of Indian Pharmacopoeia (IP) in Suriname. This was signed during the visit of the President of India to Suriname.
The parties recognize the importance of developing close cooperation and exchanging information in the field of the regulation of medicines in accordance with their respective laws and regulations and reach the following understandings:
- to accept Indian Pharmacopoeia (IP) as a book of standards for medicines in Suriname so as to ensure quality of medicines being manufactured and/or imported in Suriname;
- to accept the Certificate of Analysis issued by Indian manufacturers per IP and to do away with requirement of duplicate testing of the medicines in Suriname;
- to get IPRS and Impurity standards from IPC at reasonably low cost to be used during the quality control analysis;
- to have better scope for development of generic medicines and contributing to availability of affordable medicines in Suriname;
- to promote an understanding of pharmacopoeia in regulatory framework, requirements and processes;
- to facilitate the exchange of information and documentation relating to the development of monographs of IP;
- to enhance the ability of regulatory authorities in the provision of their services relating to or in connection with public health, to meet the needs of their respective population;
- to explore opportunities for technical cooperation in areas of mutual benefit in the development of monographs and future technologies.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.